BIO is a decentralized curation and liquidity protocol focused on advancing biotechnology through Decentralized Science (DeSci). The primary objective of BIO is to empower global communities of patients, researchers, and biotech professionals to collaboratively fund, develop, and own tokenized biotech initiatives and intellectual property (IP). The BIO team has a proven track record, having contributed to the development of platforms like Molecule, which specializes in tokenizing early-stage biomedicine, and VitaDAO, a leading decentralized community dedicated to longevity science. Building on these foundations, BIO aims to foster an on-chain scientific economy by facilitating decentralized funding mechanisms, providing incentives, and enhancing liquidity. Holders of the BIO token gain access to a vibrant network of scientific communities and intellectual property, allowing them to engage deeply with the DeSci ecosystem. This access promotes participation in innovative biotech projects and contributes to the growth of a thriving decentralized scientific environment. Overall, BIO serves as a pivotal tool in bridging the gap between biotechnology and decentralized finance, offering unique opportunities for collaboration and investment in the future of science and technology.